Michael Dellogono

Michael is currently Business Development Manager at Toxikon. Since joining Toxikon, Michael has worked extensively on medical device and pharmaceutical programs. He has a deep understanding of regulatory expectations and requirements for medical devices, pharmaceuticals, and combination devices. Michael joined Toxikon while completing his Ph.D. in Biomedical Engineering and Biotechnology at the University of Massachusetts Lowell. While there he focused on the influence of amino acids on blood glucose regulation and managed a variety of in vivo and in vitro studies. Michael combines his science education, study management skills, and business acumen to build efficient testing plans to bring products to market as quickly as possible.